Management of cancerization field with a medical device containing photolyase: A randomized, double-blind, parallel-group pilot study

At least 6 clinical studies conducted in subjects with actinic keratosis (AK) have demonstrated the therapeutic effect of Eryfotona AK-NMSC^® (ISDIN, Spain), a topically applied film-forming cream containing DNA Repairsomes^™ (broad-spectrum UV filters and the DNA-repair enzyme photolyase, encapsulated in liposomes) (1-6) (registered as medical device in Europe). Recently a German opinion paper reviewed clinical evidence for the efficacy of topical application of this topical cream. They concluded that there was strong evidence that patient at high risk for developing AK would benefit from the year around use of this product marketed in Europe in the medical device category. Eryfotona AK-NMSC has a very high photoprotection factor (SPF >100) combined with and photorepair action (DNA repair enzymes) (7).

This article is protected by copyright. All rights reserved.

http://ift.tt/2m8hIAB